Bilastic-AM Tablet
Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg Tablets — Triple Anti-Allergy / Anti-Asthma Therapy
| Composition | Bilastine 20 mg + Montelukast 10 mg + Acebrophylline 200 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Alu-Alu Blister |
| Pack Size | 10 x 10 Tablets |
| MRP | ₹ 2750 |
| Therapy | Dermatology + Anti-Allergy + Respiratory — Antihistamine + Leukotriene Antagonist + Mucolytic-Bronchodilator |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Bilastic-AM Tablet
Bilastic-AM Tablet combines three complementary anti-allergy / anti-asthma molecules: Bilastine 20 mg (H1 antihistamine), Montelukast 10 mg (cysteinyl leukotriene receptor antagonist) and Acebrophylline 200 mg (mucolytic + mild bronchodilator). The triple combination is used for patients with concurrent allergic rhinitis and bronchial asthma — the so-called ‘united airway’ phenotype that drives most chronic respiratory allergy in Indian practice.
Bilastine blocks histamine-mediated rhinitis symptoms; Montelukast blocks leukotriene-mediated bronchoconstriction and mucosal swelling; Acebrophylline reduces mucus viscosity, stimulates surfactant production and provides mild bronchodilation. Together they address the inflammatory, bronchospastic and mucus-clearance components of allergic airway disease in a single daily tablet.
Bilastic-AM is manufactured by Trumac Healthcare under WHO-GMP conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a high-margin respiratory/allergy SKU.
Indications
- Allergic rhinitis with concurrent mild-to-moderate asthma
- Persistent allergic asthma with rhinitis (united airway disease)
- Cough-variant asthma with allergic component
- Post-viral airway hyperreactivity with allergic background
Mechanism of Action
Bilastine selectively blocks H1 receptors, suppressing histamine-driven rhinitis and itch. Montelukast antagonises CysLT1 leukotriene receptors on airway smooth muscle and inflammatory cells, reducing bronchoconstriction and eosinophilic inflammation. Acebrophylline is a xanthine derivative + ambroxol salt — providing mucolytic, surfactant-stimulating and mild PDE-inhibitor bronchodilator action.
Dosage & Administration
Adults: 1 tablet once daily in the evening, swallowed whole. Re-evaluate response after 4 weeks. Step down to monotherapy when symptoms stabilise.
Side Effects
Headache, mild GI upset, somnolence (low), behavioural changes (Montelukast — black-box warning for neuropsychiatric effects; counsel patient and monitor). Acebrophylline class: occasional GI upset, palpitations, tremor.
Contraindications & Precautions
Hypersensitivity to any component. Severe hepatic impairment. Concomitant fruit juices (reduce Bilastine absorption). History of suicidal ideation (Montelukast caution). Acute severe asthma exacerbation — not for rescue therapy.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
Bilastic-AM Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Bilastic-AM Tablet used for?
Bilastic-AM combines Bilastine + Montelukast + Acebrophylline and is used for patients with concurrent allergic rhinitis and asthma — addressing rhinitis, bronchoconstriction and mucus clearance in a single daily tablet.
What is the Montelukast neuropsychiatric warning?
Montelukast has a US-FDA black-box warning for neuropsychiatric effects (mood changes, suicidal ideation). Patients and caregivers should be counselled to report any unusual mood or behavioural changes immediately.
Is Bilastic-AM available for PCD pharma franchise?
Yes, Trumac Healthcare offers Bilastic-AM Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing.
How should Bilastic-AM Tablet be stored?
Store below 30 °C in a dry place, away from direct sunlight and moisture.
Is Bilastic-AM WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Bilastic-M Tablet — Bilastine 20 mg + Montelukast 10 mg
- Bilastic-20 Tablet — Bilastine 20 mg
- Bilastic-40 Tablet — Bilastine 40 mg